Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma

Journal of Neuro-Oncology

Volumn 104, Issue 1, 2011, Pages 381-386

  Lombardi, Giuseppe ^a   Zustovich, Fable ^a   Della Puppa, Alessandro ^b   Borgato, Lucia ^a   Orvieto, Enrico ^b   Manara, Renzo ^b   Cecchin, Diego ^c   Berti, Franco ^a   Farina, Patrizia ^a   Gardiman, Marina Paolo ^b   Scienza, Renato ^b   Zagonel, Vittorina ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Brain tumor; Chemotherapy; Cisplatin; Ethmoid sinus intestinal type adenocarcinoma; Leptomeningeal metastases; Temozolomide

Indexed keywords

CISPLATIN; GADOLINIUM; TEMOZOLOMIDE;

ADENOCARCINOMA; AGED; ANEMIA; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CARCINOMATOUS MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DISEASE COURSE; DISEASE DURATION; DROWSINESS; DRUG INFUSION; EDEMA; EPISTAXIS; ETHMOID SINUS; ETHMOID SINUS INTESTINAL TYPE ADENOCARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FRONTAL LOBE; HEADACHE; HUMAN; HYDRATION; INVASIVE CARCINOMA; LUMBAR PUNCTURE; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NOSE CAVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE FRACTIONATION; SINGLE DRUG DOSE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; UNSTEADINESS; VISUAL IMPAIRMENT; VOMITING;

AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; DACARBAZINE; DRUG THERAPY, COMBINATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL CARCINOMATOSIS; SUBARACHNOID SPACE;

EID: 80052782417     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0484-2     Document Type: Article

References (32)

1. JL Llorente J Perez-Escuredo C Alvarez-Marcos C Suarez M Hermsen 2009 Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review Eur Arch Otorhinolaryngol 266 1 7 10.1007/s00405-008- 0749-y 18560862 10.1007/s00405-008-0749-y
2. C Robles EM Cooper 2004 A case of intestinal-type sinonasal adenocarcinoma J Natl Med Assoc 96 117 119 14746361 (Pubitemid 38095692)
3. L Licitra S Suardi P Bossi LD Locati L Mariani P Quattrone S Lo Vullo M Oggionni P Olmi G Cantu MA Pierotti S Pilotti 2004 Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma J Clin Oncol 22 4901 4906 10.1200/JCO.2004.05.071 15611505 10.1200/JCO.2004.05.071 1:CAS:528:DC%2BD2MXptVWktQ%3D%3D (Pubitemid 46638614)
4. D Brasnu O Laccourreye V Bassot L Laccourreye P Naudo FX Roux 1996 Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base Arch Otolaryngol Head Neck Surg 122 765 768 8663951 1:STN:280:DyaK283otVSktA%3D%3D (Pubitemid 26240023)
5. H Nagano K Yoshifuku K Deguchi Y Kurono 2010 Adenocarcinoma of the paranasal sinuses and nasal cavity with lung metastasis showing complete response to combination chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF): a case report Auris Nasus Larynx 37 238 243 10.1016/j.anl.2009.05.007 19560300 10.1016/j.anl.2009.05.007
6. O Choussy C Ferron PO Vedrine B Toussaint B Lietin P Marandas E Babin D De Raucourt E Reyt A Cosmidis M Makeiff D Dehesdin GETTEC Study Group 2008 Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases Laryngoscope 118 437 443 10.1097/MLG.0b013e31815b48e3 18176354 10.1097/MLG.0b013e31815b48e3 (Pubitemid 351640621)
7. MD Groves 2010 New strategies in the management of leptomeningeal metastases Arch Neurol 67 305 312 10.1001/archneurol.2010.18 20212228 10.1001/archneurol.2010.18
8. ES Newlands MF Stevens SR Wedge RT Wheelhouse C Brock 1997 Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials Cancer Treat Rev 23 35 61 9189180 10.1016/S0305-7372(97)90019-0 1:CAS:528:DyaK2sXktFOrt7w%3D (Pubitemid 27273454)
9. CD Britten EK Rowinsky SD Baker SS Agarwala JR Eckardt R Barrington SG Diab LA Hammond T Johnson M Villalona-Calero U Fraass P Statkevich DD Von Hoff SG Eckhardt 1999 A phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies Clin Cancer Res 5 1629 1637 10430061 1:CAS:528:DyaK1MXltVCqsbw%3D (Pubitemid 29334438)
10. F Zustovich G Lombardi A Della Puppa A Rotilio R Scienza D Pastorelli 2009 A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma Anticancer Res 29 4275 4279 19846986 1:CAS:528:DC%2BD1MXhsVOltL7L
11. B O'Sullivan J Shah 2003 New TNM staging criteria for head and neck tumors Semin Surg Oncol 21 30 42 10.1002/ssu.10019 12923914 10.1002/ssu.10019 (Pubitemid 37127472)
12. JF Vellin V Achim D Sinardet J Gabrillargues T Mom L Gilain 2007 Rapidly developing leptomeningeal carcinomatosis following anterior skull base surgery: a case report Auris Nasus Larynx 34 565 567 10.1016/j.anl.2007.03.001 17507192 10.1016/j.anl.2007.03.001 (Pubitemid 47600551)
13. BC Wen DH Hussey GH Clamon JC Godersky 1992 Leptomeningeal carcinomatosis following craniofacial resection of an ethmoid tumor J Surg Oncol 49 266 269 1556871 10.1002/jso.2930490412 1:STN:280:DyaK383htF2lug%3D%3D
14. Y Bejot A Catteau M Hervieu P Gire M Caillier I Benatru GV Osseby P Soichot T Moreau M Giroud 2008 Leptomeningeal dissemination after ethmoidal sinus adenocarcinoma surgery: a rare complication Rev Neurol (Paris) 164 189 193 10.1016/j.neurol.2007.09.001 1:STN:280:DC%2BD1czitFyqsw%3D%3D (Pubitemid 351625242)
15. A Devos M Lemmerling F Vanrietvelde F Govaere J De Bleecker M Beel M Kunnen 1999 Leptomeningeal metastases from ethmoid sinus adenocarcinoma: clinico-radiological correlation JBR-BTR 82 285 287 10670169 1:STN:280:DC%2BD3c7jsFSltw%3D%3D (Pubitemid 30046465)
16. L Licitra LD Locati R Cavina I Garassino F Mattavelli N Pizzi P Quattrone P Valagussa L Gianni G Bonadonna CL Solero G Cantu 2003 Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer Ann Oncol 14 367 372 12598339 10.1093/annonc/mdg113 1:STN:280: DC%2BD3s%2Fos1Gnug%3D%3D (Pubitemid 36367411)
17. GL Jiang WH Morrison AS Garden F Geara D Callender H Goepfert KK Ang 1998 Ethmoid sinus carcinomas: natural history and treatment results Radiother Oncol 49 21 27 9886693 10.1016/S0167-8140(98)00075-9 1:STN:280:DyaK1M7gtFOrtg%3D%3D (Pubitemid 29005199)
18. JE Byfield CL Hornbeck 1985 Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey Cancer Res 45 3398 3399 4005863 1:CAS:528:DyaL2MXksVOrsLY%3D (Pubitemid 15007224)
19. H Nakagawa T Fujita S Kubo K Tokiyoshi M Yamada T Kanayama Y Hagiwara H Nakanomyo M Hiraoka 1996 Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor Cancer Chemother Pharmacol 37 317 326 8548876 10.1007/s002800050391 1:CAS:528:DyaK28Xhs1Sht7Y%3D (Pubitemid 26031011)
20. S Ostermann C Csajka T Buclin S Leyvraz F Lejeune LA Decosterd R Stupp 2004 Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients Clin Cancer Res 10 3728 3736 10.1158/1078-0432.CCR- 03-0807 15173079 10.1158/1078-0432.CCR-03-0807 1:CAS:528:DC%2BD2cXksVKntrw%3D (Pubitemid 38697606)
21. S Siena L Crino M Danova S Del Prete S Cascinu S Salvagni I Schiavetto M Vitali E Bajetta 2010 Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study Ann Oncol 21 655 661 10.1093/annonc/mdp343 19767314 10.1093/annonc/mdp343 1:STN:280: DC%2BC3c7isVGmsA%3D%3D
22. D Chua M Krzakowski C Chouaid MG Pallotta JI Martinez M Gottfried W Curran N Throuvalas 2010 Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study Clin Lung Cancer 11 176 181 10.3816/CLC.2010.n.022 20439193 10.3816/CLC.2010.n.022 1:CAS:528: DC%2BC3cXnt1equ70%3D
23. P Perez Segura M Gil C Balana I Chacon J Munoz Langa M Marin 2010 Phase II trial of temozolomide for leptomeningeal metastases: safety and activity analysis J Clin Oncol 28 15 Suppl e12528
24. Davis TH, Fadul CE, Glantz MJ, Lewis LL, Bouchard PR, Bator TM, Gonzalez JL, Mamourian AC (2003) Pilot phase II trial of temozolomide for leptomeningeal metastases: preliminary report. Proc Am Soc Clin Oncol 22: (abstract 460)
25. AB Cortot L Geriniere G Robinet JL Breton R Corre L Falchero H Berard C Gimenez JM Chavaillon M Perol P Bombaron C Mercier PJ Souquet Groupe Lyon-Saint-Etienne d'Oncologie Thoracique, Groupe Francais de Pneumo-Cancerologie 2006 Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study Ann Oncol 17 1412 1417 10.1093/annonc/mdl146 16790516 10.1093/annonc/mdl146 1:STN:280:DC%2BD28rktVentg%3D%3D (Pubitemid 44400379)
26. E Wierzbicka-Hainaut B Sassolas L Mourey B Guillot C Bedane G Guillet JM Tourani 2010 Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial Melanoma Res 20 141 146 10.1097/CMR.0b013e3283350578 20075758 10.1097/CMR. 0b013e3283350578 1:CAS:528:DC%2BC3cXjtVOqtbs%3D (Pubitemid 351398269)
27. A Salmaggi A Silvani M Eoli E Lamperti A Boiardi 2002 Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report Neurol Sci 23 257 258 12528690 10.1007/s100720200053 1:STN:280:DC%2BD3s%2FitFKqtw%3D%3D (Pubitemid 36024573)
28. SA Grossman DM Finkelstein JC Ruckdeschel DL Trump T Moynihan DS Ettinger 1993 Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group J Clin Oncol 11 561 569 8445432 1:STN:280: DyaK3s7oslKqsA%3D%3D (Pubitemid 23071056)
29. DS Fulton VA Levin PH Gutin MS Edwards ML Seager J Stewart CB Wilson 1982 Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors Cancer Chemother Pharmacol 8 285 291 6897022 10.1007/BF00254052 1:STN:280:DyaL3s%2FisFCgsw%3D%3D (Pubitemid 12057198)
30. MJ Glantz KA Jaeckle MC Chamberlain S Phuphanich L Recht LJ Swinnen B Maria S LaFollette GB Schumann BF Cole SB Howell 1999 A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors Clin Cancer Res 5 3394 3402 10589750 1:CAS:528:DyaK1MXotV2gsL0%3D
31. KA Jaeckle T Batchelor SJ O'Day S Phuphanich P New G Lesser A Cohn M Gilbert R Aiken D Heros L Rogers E Wong D Fulton JC Gutheil S Baidas JM Kennedy W Mason P Moots C Russell LJ Swinnen SB Howell 2002 An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis J Neurooncol 57 231 239 12125986 10.1023/A:1015752331041 (Pubitemid 34692631)
32. W Boogerd MJ van den Bent PJ Koehler JJ Heimans JJ van der Sande NK Aaronson AA Hart J Benraadt ChJ Vecht 2004 The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study Eur J Cancer 40 2726 2733 10.1016/j.ejca.2004.08.012 15571954 10.1016/j.ejca.2004.08.012 1:CAS:528:DC%2BD2cXhtVahurvE (Pubitemid 39574724)